title: Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
authors.affiliation: Department of Medicine, Brown University, Providence, RI 02906, USA. Tflanigan@lifespan.org
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Flanigan
authors.forename: Kara
authors.initials: K
authors.lastname: Wools-Kaloustain
authors.forename: Joseph
authors.initials: J
authors.lastname: Harwell
authors.forename: Susan
authors.initials: S
authors.lastname: Cu-Uvin
authors.forename: Sylvester
authors.initials: S
authors.lastname: Kimaiyo
authors.forename: E Jane
authors.initials: EJ
authors.lastname: Carter
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics*; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D003695:Delivery of Health Care; D003906:Developing Countries; D023801:Directly Observed Therapy; D015658:HIV Infections / Q000188:drug therapy*; D017048:Health Care Costs; D006801:Humans; D010349:Patient Compliance; D012959:Socioeconomic Factors
chemical_list: D019380:Anti-HIV Agents